Trial Profile
The Luveris In Vitro Fertilization Trial: The Effect of Recombinant Luteinizing Hormone (LH) on Follicular Response, Oocyte Quality, and Pregnancy in In-Vitro Fertilization Treatment Cycles in Women Without Endogenous LH Activity.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lutropin alfa (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Therapeutic Use
- 09 Dec 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 20 Aug 2012 Planned end date changed from 1 Apr 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov record.
- 20 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.